Monday, July 31, 2006
Flying Spaghetti Monster hate mail
Posted by
Anonymous Coward
at
5:11 PM
2
comments
VSV contradicts evolution?
BTW blogger is terrible and not uploading images.
Posted by
Rob
at
11:37 AM
2
comments
Sunday, July 30, 2006
An alternative to FACS
Posted by
Anonymous Coward
at
1:59 PM
1 comments
Friday, July 28, 2006
Learning while being distracted
Posted by
Anonymous Coward
at
9:15 AM
0
comments
Tuesday, July 25, 2006
LAN Partying Prevents Alzheimer's, Parkinson's?
Posted by
Bayman
at
12:37 PM
1 comments
Monday, July 24, 2006
Gleevec: Tough on Leukemia, Rough On the Heart?
Imatinib mesylate (or Gleevec), a small-molecule inhibitor of the ABL kinase, is, as we all know, the flagship of the molecularly-targeted cancer therapeutics. According to the Novartis literature (and lots of other people I'm sure) it cures a lot of patients with chronic myeloid leukemias (CMLs) expressing the BCR-ABL gene fusion (ie the famous Philadelphia chromosome). That same literature claims that the drug has no important toxicity, so they apparently didn't notice when patients' hearts started conking out, despite their lack of prior cardiac problems. Some clinicians were paying attention, and they now report on congestive heart failure in 10 patients and cardiotoxicity observed upon adminsitration of gleevec to healthy mice in Nature Medicine. This study highlights the important need to study the potential side effects of new drugs, something that a lot of drug companies financing their development would rather we forget. Not that gleevec should be pulled from the market - CML is obviously a serious and hard-to-treat disease and the benefits might be worth risking the cardiotoxiticy. Then again, heart failure is pretty serious too and the risk might not be worth it. Obviously then what's needed is more detailed and quantitative study of the cardiotoxic risk associated with Gleevec so that clinicians and patients can make the most informed decisions. It's interesting to note that the cardiotoxicity now reported can apparently be observed simply by giving the drug to mice and examining their hearts. It's hard to believe Novartis couldn't have done that during more than a decade of preclinical investigation, but probably typical of the way drug research is currently being carried out. As a result patients are less informed and ultimately the companies themselves risk knee-jerk public reaction and their products getting pulled off the market when bad things start happening. Another important point made here is that even the most well-targeted drugs can have side effects - all the more reason to investigate toxicities as thoroughly as possible and be more open to examining not just the more profitable small molecule drugs, but all other possible types of novel therapeutics.
Posted by
Bayman
at
10:15 PM
1 comments
Friday, July 21, 2006
More Cool Genetics
So a month or so ago a paramutation phenomenon involving non-mendelian inheritance was discovered in mice. Evidence in that paper suggested that genetic information was passed on through a germ cell pool of RNA in addition to DNA. Interestingly, another Nature paper now shows that the more well-known phenomenon of paramutation in Maize relies on an RNA-dependent RNA polymerase known to be involved in the production of siRNAs. The idea is that this enzyme makes RNA molecules that affect heritable chromatin states that in turn affect transcriptional activity.
Posted by
Bayman
at
10:03 AM
2
comments
Non-specific effects of DMSO
Posted by
Anonymous Coward
at
9:40 AM
1 comments
Thursday, July 20, 2006
Biological Noise
Apparently there is a yeast library with every protein C-terminally tagged with GFP. These guys used it to study the expression variation between individual cells. (Nature access required) Interestingly it was environmental response/ stress response genes that showed the most variability. They suggest this is an aquired adaptation so that a genetically homogenous population contains enough variability to adapt to a changing environment.
Posted by
Rob
at
1:20 PM
0
comments
Tuesday, July 18, 2006
Bird Flu and my Tamiflu Stocks
Posted by
Rob
at
11:41 AM
3
comments
Wednesday, July 12, 2006
What makes a good PhD student
"
- Choose a supervisor whose work you admire and who is well supported by grants and departmental infrastructure.
- Take responsibility for your project.
- Work hard — long days all week and part of most weekends. If research is your passion this should be easy, and if it isn't, you are probably in the wrong field. Note who goes home with a full briefcase to work on at the end of the day. This is a cause of success, not a consequence.
- Take some weekends off, and decent holidays, so you don't burn out.
- Read the literature in your immediate area, both current and past, and around it. You can't possibly make an original contribution to the literature unless you know what is already there.
- Plan your days and weeks carefully to dovetail experiments so that you have a minimum amount of downtime.
- Keep a good lab book and write it up every day.
- Be creative. Think about what you are doing and why, and look for better ways to go. Don't see your PhD as just a road map laid out by your supervisor.
- Develop good writing skills: they will make your scientific career immeasurably easier.
- To be successful you must be at least four of the following: smart, motivated, creative, hard-working, skilful and lucky. You can't depend on luck, so you had better focus on the others!"
- "
Posted by
Anonymous Coward
at
5:10 PM
0
comments
Popular Science Blogs
Posted by
Kamel
at
11:33 AM
0
comments
Tuesday, July 11, 2006
Public sales of chemicals to be made illegal
Posted by
Anonymous Coward
at
3:29 PM
1 comments
Systematic study of magic mushroom
Posted by
Anonymous Coward
at
1:40 PM
0
comments
Sharing data
With all this talk of patents around here I think the question of wether scientists actually share their data is an interresting one. Patents, at least initially, were designed to give some protection so that data could be shared. Public access to scientific findings is making progress, and my favorite open access journal PLOS has two interresting articles on mandatory open access to federally funded reasearch findings and on the poor rate of sharing of sequences on genbank...food for thoughts.
Posted by
Anonymous Coward
at
10:06 AM
0
comments
Monday, July 10, 2006
Who said scientists don't get the ladies?
Posted by
Anonymous Coward
at
11:48 AM
2
comments
Sunday, July 09, 2006
Discover Your Own miRNA
Posted by
Bayman
at
11:51 PM
0
comments
Wednesday, July 05, 2006
Peer to Patent
I ganked the link from the authoratative IA linkness. Seems like they are going to try some sort of social networking patenting process. I wonder how that would work in biotech as opposed to IT, which is I'm sure where they are going to try it out first.
Posted by
Rob
at
4:29 PM
1 comments
Who is doing the research?

Google came out with this "google trends" search tool, that enables you to look at the popularity of certain search terms and their geographic location. Just for fun I searched things like "siRNA" ,"stem cell", "microarray" etc... Interrestingly you can figure out this way what technologies are rising or declinning in popularity, but also which cities are most active in research. If you look at the top ten, you'll find obvious ones like LaJolla, or Boston. But to my surprise Seoul, Singapour, Taipei and Beijing consistantly appear in the list. If this is a real trend, expect much more research and discoveries coming from the Far East in the years to come... Just check the regional searches for siRNA:
| 1. | South Korea | | ||
| 2. | Taiwan | | ||
| 3. | Singapore | | ||
| 4. | Israel | | ||
| 5. | India | | ||
| 6. | Switzerland | | ||
| 7. | United States | | ||
| 8. | Japan | | ||
| 9. | Germany | | ||
| 10. | Denmark |
Posted by
Anonymous Coward
at
11:03 AM
2
comments
Sunday, July 02, 2006
What's with the Hockey Stick? I'd be Happy with Tomorrow Morning's Forecast
Posted by
Bayman
at
11:57 PM
2
comments

Podcast

2 comments:
Post a Comment